Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist, the next breakthrough for obesity
True monthly cost is $179 at the monthly tier, dropping to $135/mo on the 12-month bundle
The analyses based on a traditional active-comparator new-user design using the first treatment episode during the study period included 131,298 new users of DPP4 inhibitors vs 133,233 new users of sulfonylureas and 53,302 new users of GLP-1-receptor agonists vs 146,294 new users of sulfonylureas who remained at risk at 1 year after start of follow-up (ESM Fig
doi: 10.3892/ijo_00000748 61 FadeelBOrreniusS
US$ 27.76
US$ 23.39
US$ 21.95
US$ 24.25
US$ 24.85
US$ 24.13
